	US 12,213,505 B2
	Composition for promoting restful sleep and methods of making and using the same
David Wilfred Lafond, Galesburg, MI (US); Christine Lynn O'Neil, Jupiter, FL (US); and Jean-Pierre Montmayeur, Atlanta, GA (US)
Assigned to Healthy Ingredient Solutions, LLC, Jupiter, FL (US)
Filed by Celesta Company LLC, Galesburg, MI (US)
Filed on Jun. 30, 2022, as Appl. No. 17/855,430.
Claims priority of provisional application 63/218,457, filed on Jul. 5, 2021.
Prior Publication US 2023/0039674 A1, Feb. 9, 2023
Int. Cl. A23L 33/105 (2016.01); A23L 2/52 (2006.01); A61K 9/00 (2006.01); A61K 31/05 (2006.01); A61K 31/122 (2006.01); A61K 31/194 (2006.01); A61K 31/198 (2006.01); A61K 31/352 (2006.01); A61K 31/4045 (2006.01); A61K 31/4415 (2006.01); A61K 31/7004 (2006.01); A61K 31/7016 (2006.01); A61K 33/06 (2006.01)

CPC A23L 33/105 (2016.08) [A23L 2/52 (2013.01); A61K 9/0095 (2013.01); A61K 31/05 (2013.01); A61K 31/122 (2013.01); A61K 31/194 (2013.01); A61K 31/198 (2013.01); A61K 31/352 (2013.01); A61K 31/4045 (2013.01); A61K 31/4415 (2013.01); A61K 31/7004 (2013.01); A61K 31/7016 (2013.01); A61K 33/06 (2013.01)]

18 Claims

1. A dietary composition formulated in a therapeutic effective amount to promote restful sleep in humans or animals consisting of a blend of:

a first substance selected from the group consisting of humulone, xanthohumol, myrcenol, and combinations thereof;

a second substance selected from the group consisting of honokiol, magnolol, and combinations thereof;

a third substance selected from the group consisting of rosavine, tyrosol, salidroside, and combinations thereof;

a fourth substance selected from the group consisting of rosmarinic acid, epigallocatechin gallate, and combinations thereof;

melatonin;

L-theanine;

magnesium;

vitamin B6 and

optionally an excipient;

wherein the dietary composition is in the form of a pill, a capsule, a tablet, a softgel, a lozenge, a powder, a liquid, a food, a beverage, a gummy, or an orally-dissolving film strip.